KALA WILSON: Open Payments
NPI 1376670570 · COLUMBUS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$398 in 14 payments from 7 companies in 2025. Trend: 2023 $282 · 2024 $279 · 2025 $398
Food & beverage: $303Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $147 |
| ABBVIE INC. | 4 | $100 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Amgen Inc. | 2 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Incyte Corporation | 1 | $19 |
Products named: TREMFYA, SKYRIZI, COSENTYX, OTEZLA, Sotyktu, DUPIXENT, OPZELURA.
Industry payments across MS — which companies pay providers there.
